🔎 Trials Near Me

Home › Psychotic Disorders › NCT06194344

The Effectiveness of Individualized Imagery Scripts on Sleep, Psychosis, and Suicidality Among Inpatients With Psychosis

Recruiting

The Effectiveness of Individualized Imagery Scripts on Sleep, Psychosis, and Suicidality Among Inpatients With Psychosis: A Randomized Control Pilot Study

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* primary diagnoses of schizophrenia spectrum disorder or mood disorder with psychotic features, as determined by the treatment team or record review
* capacity to consent to the study as determined by licensed psychologists ( or the primary attending psychiatrist
* reported sleep dysfunction which will be determined by a subthreshold or more severe score ≥ 8 on the Insomnia Severity Index (ISI), and/or report experiencing nightmares at least once a week.

Exclusion Criteria:

* primary substance- or medical-induced psychosis
* intellectual and developmental disabilities
* neurodegenerative cognitive disorders
* implanted devices (e.g., Pacemakers)
* on one-to-one supervision or 15-minute safety checks for suicidality or aggression
* patients with roommates that are on 15-minute checks to minimize impact on study participants' awakenings

About the study

The purpose of this study is to see how feasible is the use of compact EEG and paired audio technology to administer sleep interventions for inpatients with psychosis, to see if individuals that receive individualized technology-based sleep interventions experience improvements in sleep quality and to see if individuals that receive individualized technology-based sleep interventions experience improvements in symptomatology

What is being tested

Sponsor: The University of Texas Health Science Center, Houston · Participants: 40 · Started: Mar 5, 2024

Contact the study team

Official record on ClinicalTrials.gov — NCT06194344

Locations in the U.S.

TexasThe University of Texas Health Science Center at Houston, Houston

Conditions

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.